LINC01226 promotes gastric cancer progression through enhancing cytoplasm-to-nucleus translocation of STIP1 and stabilizing β-catenin protein
Cancer Letters · 2023
DOI: 10.1016/j.canlet.2023.216436 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2023. Verfasst von Hui Hua und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Provincial Key Laboratory of Radiation Oncology, Cancer Research Center, Shandong Cancer Hospital and Institute, Shandong First Medical Univ…. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Stomach Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 87 Literaturangaben.
Abstract (Originalsprache)
Gastric cancer (GC) remains one of the most common malignances and the leading cause of cancer-related mortality worldwide. Although the critical role of several long non-coding RNAs (lncRNAs) transcribed from several GC-risk loci has been established, we still know little about the biological significance of these lncRNAs at most gene loci and how they play in cell signaling. In the present study, we identified a novel oncogenic lncRNA LINC01226 transcribed from the 1p35.2 GC-risk locus. LINC01226 shows markedly higher expression levels in GC specimens compared with those in normal tissues. High expression of LINC01226 is evidently correlated with worse prognosis of GC cases. In line with these, oncogenic LINC01226 promotes proliferation, migration and metastasis of GC cells ex vivo and in vivo. Importantly, LINC01226 binds to STIP1 protein, leads to disassembly of the STIP1-HSP90 complex, elevates interactions between HSP90 and β-catenin, stabilizes β-catenin protein, activates the Wnt/β-catenin signaling and, thereby, promote GC progression. Together, our findings uncovered a novel layer regulating the Wnt signaling in cancers and uncovers a new epigenetic mode of GC tumorigenesis. These discoveries also shed new light on the importance of functional lncRNAs as innovative therapeutic targets through precisely controlling protein-protein interactions in cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shandong Provincial Key Laboratory of Radiation Oncology, Cancer Research Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong Provi…
- Shandong University Cancer Center, Jinan, Shandong Province, 250117, China.
- Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong Province, 250117, China; Jiangsu Key Lab of Cancer Bi…
Zitieren
APA
Hua, H., Su, T., Han, L., Zhang, L., Huang, Y., Zhang, N., & Yang, M. (2023). LINC01226 promotes gastric cancer progression through enhancing cytoplasm-to-nucleus translocation of STIP1 and stabilizing β-catenin protein. Cancer Letters. https://doi.org/10.1016/j.canlet.2023.216436
Vancouver
Hua H, Su T, Han L, Zhang L, Huang Y, Zhang N, et al. LINC01226 promotes gastric cancer progression through enhancing cytoplasm-to-nucleus translocation of STIP1 and stabilizing β-catenin protein. Cancer Letters. 2023. doi:10.1016/j.canlet.2023.216436
BibTeX
@article{Hua2023,
author = {Hua, Hui and Su, Tao and Han, Linyu and Zhang, Long and Huang, Yizhou and Zhang, Nasha and Yang, Ming},
title = {LINC01226 promotes gastric cancer progression through enhancing cytoplasm-to-nucleus translocation of STIP1 and stabilizing β-catenin protein},
journal = {Cancer Letters},
year = {2023},
doi = {10.1016/j.canlet.2023.216436}
}
EUVIMED